IONS
HealthcareIonis Pharmaceuticals, Inc.
$71.19-1.15 (-1.59%)
Prev Close
$72.34
Open
$73.21
High
$74.16
Low
$70.42
Volume
1.44M
Market Cap
$11.76B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Ionis Pharmaceuticals, Inc. (IONS) has been dominated by selling, with 1 insider purchase totaling $477.9K and 107 insider sales totaling $158.64M. The most recent insider transaction was by Baroldi Joseph (officer: EVP, Chief Business Officer), who sold $511.9K worth of shares on Mar 5, 2026. Ionis Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $11.76B.
Buys (12M)
1
$477.9K
Sells (12M)
107
$158.64M
Net Activity
Net Seller
$158.16M
Active Insiders
19
last 12 mo
IONS Price Chart
IONS Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026↗ | Baroldi Joseph | officer: EVP, Chief Business Officer | Sell | 6,421 | $79.73 | $511.9K | 41,317 |
| Mar 5, 2026↗ | BENNETT C FRANK | officer: EVP, Chief Scientific Officer | Sell | 85,089 | $79.23 | $6.74M | 94,043 |
| Mar 5, 2026↗ | Devers Shannon L. | officer: EVP, Chief Human Resources Ofc | Sell | 20,106 | $79.40 | $1.60M | 28,326 |
| Mar 5, 2026↗ | Diaz Allene M. | director | Sell | 54,878 | $79.35 | $4.35M | 19,424 |
| Mar 5, 2026↗ | KLEIN JOSEPH III | director | Sell | 21,332 | $79.51 | $1.70M | 18,820 |
| Mar 5, 2026↗ | LOSCALZO JOSEPH | director | Sell | 1,032 | $80.26 | $82.8K | 36,330 |
| Feb 13, 2026↗ | PARSHALL B LYNNE | director | Sell | 5,000 | $82.72 | $413.6K | 56,344 |
| Feb 13, 2026↗ | Swayze Eric | officer: EVP Research | Sell | 31,284 | $81.76 | $2.56M | 38,312 |
| Feb 11, 2026↗ | PARSHALL B LYNNE | Director | Sell | 5,000 | $82.72 | $413.6K | 0 |
| Feb 10, 2026↗ | Monia Brett P | director, officer: Chief Executive Officer | Sell | 29,430 | $85.79 | $2.52M | 254,497 |
| Feb 6, 2026↗ | Monia Brett P | Chief Executive Officer | Sell | 29,430 | $85.79 | $2.52M | 0 |
| Feb 4, 2026↗ | BENNETT C FRANK | officer: EVP, Chief Scientific Officer | Sell | 36,463 | $82.79 | $3.02M | 80,293 |
| Feb 2, 2026↗ | Baroldi Joseph | officer: EVP, Chief Business Officer | Sell | 5,296 | $82.96 | $439.4K | 45,413 |
| Feb 2, 2026↗ | BENNETT C FRANK | officer: EVP, Chief Scientific Officer | Sell | 90,974 | $82.93 | $7.54M | 100,293 |
| Feb 2, 2026↗ | Birchler Brian | officer: EVP, Corp and Development Ops | Sell | 6,179 | $83.03 | $513.0K | 66,247 |
| Feb 2, 2026↗ | HOUGEN ELIZABETH L | officer: EVP, Finance & CFO | Sell | 6,988 | $83.24 | $581.7K | 132,881 |
| Feb 2, 2026↗ | Monia Brett P | director, officer: Chief Executive Officer | Sell | 62,970 | $82.72 | $5.21M | 283,927 |
| Feb 2, 2026↗ | O'NEIL PATRICK R. | officer: EVP CLO & General Counsel | Sell | 6,179 | $83.53 | $516.2K | 71,983 |
| Feb 2, 2026↗ | Schneider Eugene | officer: EVP, Chf Clinical Develop Ofcr | Sell | 6,179 | $83.45 | $515.6K | 69,702 |
| Feb 2, 2026↗ | Swayze Eric | officer: EVP Research | Sell | 6,179 | $82.93 | $512.4K | 47,747 |
| Jan 29, 2026↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 5,296 | $82.96 | $439.4K | 0 |
| Jan 29, 2026↗ | BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 5,885 | $82.95 | $488.1K | 0 |
| Jan 29, 2026↗ | Birchler Brian | EVP, Corp and Development Ops | Sell | 6,179 | $83.03 | $513.0K | 0 |
| Jan 29, 2026↗ | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | 6,988 | $83.24 | $581.7K | 0 |
| Jan 29, 2026↗ | Monia Brett P | Chief Executive Officer | Sell | 62,970 | $82.72 | $5.21M | 0 |
| Jan 29, 2026↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 6,179 | $83.53 | $516.2K | 0 |
| Jan 29, 2026↗ | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | 6,179 | $83.45 | $515.6K | 0 |
| Jan 29, 2026↗ | Swayze Eric | EVP Research | Sell | 6,179 | $82.93 | $512.4K | 0 |
| Jan 23, 2026↗ | Devers Shannon L. | officer: EVP, Chief Human Resources Ofc | Sell | 3,977 | $81.34 | $323.5K | 22,541 |
| Jan 22, 2026↗ | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | 3,977 | $81.34 | $323.5K | 0 |
| Jan 20, 2026↗ | Baroldi Joseph | officer: EVP, Chief Business Officer | Sell | 8,056 | $75.75 | $610.3K | 40,431 |
| Jan 20, 2026↗ | BENNETT C FRANK | officer: EVP, Chief Scientific Officer | Sell | 8,977 | $75.15 | $674.6K | 94,757 |
| Jan 20, 2026↗ | Birchler Brian | officer: EVP, Corp and Development Ops | Sell | 8,480 | $75.11 | $636.9K | 60,435 |
| Jan 20, 2026↗ | Devers Shannon L. | officer: EVP, Chief Human Resources Ofc | Sell | 8,353 | $75.95 | $634.4K | 26,518 |
| Jan 20, 2026↗ | HOUGEN ELIZABETH L | officer: EVP, Finance & CFO | Sell | 12,922 | $75.22 | $972.0K | 126,307 |
| Jan 20, 2026↗ | Jenne Kyle | officer: EVP, Chf GL Pdt Str Ofcr | Sell | 1,823 | $75.96 | $138.5K | 16,389 |
| Jan 20, 2026↗ | Kordasiewicz Holly B. | officer: EVP, Chief Development Officer | Sell | 4,141 | $75.66 | $313.3K | 14,718 |
| Jan 20, 2026↗ | Monia Brett P | director, officer: Chief Executive Officer | Sell | 44,034 | $74.82 | $3.29M | 224,683 |
| Jan 20, 2026↗ | O'NEIL PATRICK R. | officer: EVP CLO & General Counsel | Sell | 9,191 | $75.84 | $697.0K | 66,171 |
| Jan 20, 2026↗ | Schneider Eugene | officer: EVP, Chf Clinical Develop Ofcr | Sell | 9,302 | $75.59 | $703.1K | 63,890 |
| Jan 20, 2026↗ | Swayze Eric | officer: EVP Research | Sell | 9,933 | $75.34 | $748.4K | 41,935 |
| Jan 15, 2026↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 8,056 | $75.75 | $610.3K | 0 |
| Jan 15, 2026↗ | BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 8,977 | $75.15 | $674.6K | 0 |
| Jan 15, 2026↗ | Birchler Brian | EVP, Corp and Development Ops | Sell | 8,480 | $75.11 | $636.9K | 0 |
| Jan 15, 2026↗ | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | 8,353 | $75.95 | $634.4K | 0 |
| Jan 15, 2026↗ | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | 12,922 | $75.22 | $972.0K | 0 |
| Jan 15, 2026↗ | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | Sell | 1,823 | $75.96 | $138.5K | 0 |
| Jan 15, 2026↗ | Kordasiewicz Holly B. | EVP, Chief Development Officer | Sell | 4,141 | $75.66 | $313.3K | 0 |
| Jan 15, 2026↗ | Monia Brett P | Chief Executive Officer | Sell | 44,034 | $74.82 | $3.29M | 0 |
| Jan 15, 2026↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 9,191 | $75.84 | $697.0K | 0 |
| Jan 15, 2026↗ | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | 9,302 | $75.59 | $703.1K | 0 |
| Jan 15, 2026↗ | Swayze Eric | EVP Research | Sell | 9,933 | $75.34 | $748.4K | 0 |
| Jan 9, 2026↗ | Devers Shannon L. | officer: EVP, Chief Human Resources Ofc | Sell | 11,365 | $84.76 | $963.3K | 17,494 |
| Jan 7, 2026↗ | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | 44,199 | $85.08 | $3.76M | 0 |
| Jan 6, 2026↗ | Swayze Eric | officer: EVP Research | Sell | 23,463 | $79.12 | $1.86M | 30,453 |
| Jan 2, 2026↗ | Swayze Eric | EVP Research | Sell | 23,463 | $79.12 | $1.86M | 0 |
| Dec 1, 2025↗ | WENDER JOSEPH H | Director | Sell | 28,000 | $80.82 | $2.26M | 0 |
| Nov 25, 2025↗ | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | 16,777 | $80.91 | $1.36M | 0 |
| Nov 25, 2025↗ | KLEIN JOSEPH III | Director | Sell | 12,000 | $80.00 | $960.0K | 0 |
| Nov 19, 2025↗ | HERMAN JOAN E | Director | Sell | 44,000 | $72.13 | $3.17M | 0 |
| Nov 6, 2025↗ | Birchler Brian | EVP, Corp and Development Ops | Sell | 8,000 | $76.17 | $609.4K | 0 |
| Nov 5, 2025↗ | Geary Richard S | EVP, Chief Development Officer | Sell | 34,639 | $75.69 | $2.62M | 0 |
| Oct 31, 2025↗ | Geary Richard S | EVP, Chief Development Officer | Sell | 90,929 | $75.11 | $6.83M | 0 |
| Oct 31, 2025↗ | LOSCALZO JOSEPH | Director | Sell | 16,000 | $75.10 | $1.20M | 0 |
| Oct 30, 2025↗ | WENDER JOSEPH H | Director | Sell | 28,000 | $74.02 | $2.07M | 0 |
| Oct 15, 2025↗ | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | 7,263 | $73.06 | $530.6K | 0 |
| Oct 15, 2025↗ | PARSHALL B LYNNE | Director | Sell | 5,000 | $71.74 | $358.7K | 0 |
| Oct 15, 2025↗ | Swayze Eric | EVP Research | Sell | 53 | $73.62 | $3.9K | 0 |
| Oct 14, 2025↗ | Birchler Brian | EVP, Corp and Development Ops | Sell | 23,900 | $72.13 | $1.72M | 0 |
| Oct 6, 2025↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 1,625 | $69.37 | $112.7K | 0 |
| Oct 6, 2025↗ | Monia Brett P | Chief Executive Officer | Sell | 437 | $69.26 | $30.3K | 0 |
| Oct 6, 2025↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 13,441 | $69.74 | $937.3K | 0 |
| Oct 6, 2025↗ | Swayze Eric | EVP Research | Sell | 6,849 | $69.02 | $472.7K | 0 |
| Oct 2, 2025↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 15,000 | $68.01 | $1.02M | 0 |
| Oct 2, 2025↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 64,664 | $67.69 | $4.38M | 0 |
| Oct 1, 2025↗ | Swayze Eric | EVP Research | Sell | 27,114 | $66.16 | $1.79M | 0 |
| Oct 1, 2025↗ | WENDER JOSEPH H | Director | Sell | 16,800 | $65.50 | $1.10M | 0 |
| Sep 30, 2025↗ | Geary Richard S | EVP, Chief Development Officer | Sell | 57,900 | $65.24 | $3.78M | 0 |
| Sep 30, 2025↗ | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | 49,800 | $65.26 | $3.25M | 0 |
| Sep 29, 2025↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 25,300 | $64.62 | $1.63M | 0 |
| Sep 12, 2025↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 1,700 | $64.58 | $109.8K | 0 |
| Sep 9, 2025↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 11,950 | $62.16 | $742.8K | 0 |
| Sep 9, 2025↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 21,000 | $64.56 | $1.36M | 0 |
| Sep 5, 2025↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 250 | $62.00 | $15.5K | 0 |
| Sep 5, 2025↗ | BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 6,000 | $59.60 | $357.6K | 0 |
| Sep 3, 2025↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 32,800 | $59.34 | $1.95M | 0 |
| Sep 3, 2025↗ | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | 3,162 | $61.02 | $192.9K | 0 |
| Sep 3, 2025↗ | KLEIN JOSEPH III | Director | Sell | 56,000 | $60.00 | $3.36M | 0 |
| Sep 3, 2025↗ | LOSCALZO JOSEPH | Director | Sell | 16,000 | $60.15 | $962.4K | 0 |
| Sep 3, 2025↗ | Monia Brett P | Chief Executive Officer | Sell | 203,814 | $60.32 | $12.29M | 0 |
| Sep 3, 2025↗ | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | 19,658 | $60.81 | $1.20M | 0 |
| Sep 2, 2025↗ | BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 38,909 | $59.14 | $2.30M | 0 |
| Sep 2, 2025↗ | Geary Richard S | EVP, Chief Development Officer | Sell | 10,000 | $50.37 | $503.7K | 0 |
| Sep 2, 2025↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 89,900 | $60.03 | $5.40M | 0 |
| Sep 2, 2025↗ | PARSHALL B LYNNE | Director | Sell | 20,000 | $50.92 | $1.02M | 0 |
| Sep 2, 2025↗ | Swayze Eric | EVP Research | Sell | 11,130 | $49.67 | $552.9K | 0 |
| Sep 2, 2025↗ | WENDER JOSEPH H | Director | Sell | 56,000 | $57.58 | $3.22M | 0 |
| Aug 22, 2025↗ | Diaz Allene M. | Director | Sell | 1,427 | $42.53 | $60.7K | 0 |
| Aug 18, 2025↗ | BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 10,000 | $43.98 | $439.8K | 0 |
| Aug 6, 2025↗ | PARSHALL B LYNNE | Director | Sell | 5,000 | $41.93 | $209.6K | 0 |
| Aug 5, 2025↗ | Geary Richard S | EVP, Chief Development Officer | Sell | 10,000 | $42.86 | $428.6K | 0 |
| Aug 4, 2025↗ | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | 9,549 | $42.80 | $408.7K | 0 |
| Jul 30, 2025↗ | Monia Brett P | Chief Executive Officer | Sell | 2,432 | $45.00 | $109.4K | 0 |
| Jul 11, 2025↗ | Monia Brett P | Chief Executive Officer | Sell | 1,160 | $41.74 | $48.4K | 0 |
| May 1, 2025↗ | Hayden Michael R | Director | Buy | 15,000 | $31.86 | $477.9K | 0 |
| Apr 15, 2025↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 3,928 | $28.40 | $111.6K | 0 |
| Apr 15, 2025↗ | Birchler Brian | EVP, Corp and Development Ops | Sell | 680 | $28.37 | $19.3K | 0 |
| Apr 15, 2025↗ | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | Sell | 3,016 | $28.36 | $85.5K | 0 |
| Mar 11, 2025↗ | Monia Brett P | Chief Executive Officer | Sell | 140 | $32.32 | $4.5K | 0 |
| Feb 20, 2025↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 1,207 | $32.35 | $39.0K | 0 |
IONS Insider Buying Activity
The following table shows recent insider purchases of Ionis Pharmaceuticals, Inc. (IONS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| May 1, 2025↗ | Hayden Michael R | Director | Buy | 15,000 | $31.86 | $477.9K | 0 |
IONS Insider Selling Activity
The following table shows recent insider sales of Ionis Pharmaceuticals, Inc. (IONS) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026↗ | Baroldi Joseph | officer: EVP, Chief Business Officer | Sell | 6,421 | $79.73 | $511.9K | 41,317 |
| Mar 5, 2026↗ | BENNETT C FRANK | officer: EVP, Chief Scientific Officer | Sell | 85,089 | $79.23 | $6.74M | 94,043 |
| Mar 5, 2026↗ | Devers Shannon L. | officer: EVP, Chief Human Resources Ofc | Sell | 20,106 | $79.40 | $1.60M | 28,326 |
| Mar 5, 2026↗ | Diaz Allene M. | director | Sell | 54,878 | $79.35 | $4.35M | 19,424 |
| Mar 5, 2026↗ | KLEIN JOSEPH III | director | Sell | 21,332 | $79.51 | $1.70M | 18,820 |
| Mar 5, 2026↗ | LOSCALZO JOSEPH | director | Sell | 1,032 | $80.26 | $82.8K | 36,330 |
| Feb 13, 2026↗ | PARSHALL B LYNNE | director | Sell | 5,000 | $82.72 | $413.6K | 56,344 |
| Feb 13, 2026↗ | Swayze Eric | officer: EVP Research | Sell | 31,284 | $81.76 | $2.56M | 38,312 |
| Feb 11, 2026↗ | PARSHALL B LYNNE | Director | Sell | 5,000 | $82.72 | $413.6K | 0 |
| Feb 10, 2026↗ | Monia Brett P | director, officer: Chief Executive Officer | Sell | 29,430 | $85.79 | $2.52M | 254,497 |
| Feb 6, 2026↗ | Monia Brett P | Chief Executive Officer | Sell | 29,430 | $85.79 | $2.52M | 0 |
| Feb 4, 2026↗ | BENNETT C FRANK | officer: EVP, Chief Scientific Officer | Sell | 36,463 | $82.79 | $3.02M | 80,293 |
| Feb 2, 2026↗ | Baroldi Joseph | officer: EVP, Chief Business Officer | Sell | 5,296 | $82.96 | $439.4K | 45,413 |
| Feb 2, 2026↗ | BENNETT C FRANK | officer: EVP, Chief Scientific Officer | Sell | 90,974 | $82.93 | $7.54M | 100,293 |
| Feb 2, 2026↗ | Birchler Brian | officer: EVP, Corp and Development Ops | Sell | 6,179 | $83.03 | $513.0K | 66,247 |
| Feb 2, 2026↗ | HOUGEN ELIZABETH L | officer: EVP, Finance & CFO | Sell | 6,988 | $83.24 | $581.7K | 132,881 |
| Feb 2, 2026↗ | Monia Brett P | director, officer: Chief Executive Officer | Sell | 62,970 | $82.72 | $5.21M | 283,927 |
| Feb 2, 2026↗ | O'NEIL PATRICK R. | officer: EVP CLO & General Counsel | Sell | 6,179 | $83.53 | $516.2K | 71,983 |
| Feb 2, 2026↗ | Schneider Eugene | officer: EVP, Chf Clinical Develop Ofcr | Sell | 6,179 | $83.45 | $515.6K | 69,702 |
| Feb 2, 2026↗ | Swayze Eric | officer: EVP Research | Sell | 6,179 | $82.93 | $512.4K | 47,747 |
| Jan 29, 2026↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 5,296 | $82.96 | $439.4K | 0 |
| Jan 29, 2026↗ | BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 5,885 | $82.95 | $488.1K | 0 |
| Jan 29, 2026↗ | Birchler Brian | EVP, Corp and Development Ops | Sell | 6,179 | $83.03 | $513.0K | 0 |
| Jan 29, 2026↗ | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | 6,988 | $83.24 | $581.7K | 0 |
| Jan 29, 2026↗ | Monia Brett P | Chief Executive Officer | Sell | 62,970 | $82.72 | $5.21M | 0 |
| Jan 29, 2026↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 6,179 | $83.53 | $516.2K | 0 |
| Jan 29, 2026↗ | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | 6,179 | $83.45 | $515.6K | 0 |
| Jan 29, 2026↗ | Swayze Eric | EVP Research | Sell | 6,179 | $82.93 | $512.4K | 0 |
| Jan 23, 2026↗ | Devers Shannon L. | officer: EVP, Chief Human Resources Ofc | Sell | 3,977 | $81.34 | $323.5K | 22,541 |
| Jan 22, 2026↗ | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | 3,977 | $81.34 | $323.5K | 0 |
| Jan 20, 2026↗ | Baroldi Joseph | officer: EVP, Chief Business Officer | Sell | 8,056 | $75.75 | $610.3K | 40,431 |
| Jan 20, 2026↗ | BENNETT C FRANK | officer: EVP, Chief Scientific Officer | Sell | 8,977 | $75.15 | $674.6K | 94,757 |
| Jan 20, 2026↗ | Birchler Brian | officer: EVP, Corp and Development Ops | Sell | 8,480 | $75.11 | $636.9K | 60,435 |
| Jan 20, 2026↗ | Devers Shannon L. | officer: EVP, Chief Human Resources Ofc | Sell | 8,353 | $75.95 | $634.4K | 26,518 |
| Jan 20, 2026↗ | HOUGEN ELIZABETH L | officer: EVP, Finance & CFO | Sell | 12,922 | $75.22 | $972.0K | 126,307 |
| Jan 20, 2026↗ | Jenne Kyle | officer: EVP, Chf GL Pdt Str Ofcr | Sell | 1,823 | $75.96 | $138.5K | 16,389 |
| Jan 20, 2026↗ | Kordasiewicz Holly B. | officer: EVP, Chief Development Officer | Sell | 4,141 | $75.66 | $313.3K | 14,718 |
| Jan 20, 2026↗ | Monia Brett P | director, officer: Chief Executive Officer | Sell | 44,034 | $74.82 | $3.29M | 224,683 |
| Jan 20, 2026↗ | O'NEIL PATRICK R. | officer: EVP CLO & General Counsel | Sell | 9,191 | $75.84 | $697.0K | 66,171 |
| Jan 20, 2026↗ | Schneider Eugene | officer: EVP, Chf Clinical Develop Ofcr | Sell | 9,302 | $75.59 | $703.1K | 63,890 |
| Jan 20, 2026↗ | Swayze Eric | officer: EVP Research | Sell | 9,933 | $75.34 | $748.4K | 41,935 |
| Jan 15, 2026↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 8,056 | $75.75 | $610.3K | 0 |
| Jan 15, 2026↗ | BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 8,977 | $75.15 | $674.6K | 0 |
| Jan 15, 2026↗ | Birchler Brian | EVP, Corp and Development Ops | Sell | 8,480 | $75.11 | $636.9K | 0 |
| Jan 15, 2026↗ | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | 8,353 | $75.95 | $634.4K | 0 |
| Jan 15, 2026↗ | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | 12,922 | $75.22 | $972.0K | 0 |
| Jan 15, 2026↗ | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | Sell | 1,823 | $75.96 | $138.5K | 0 |
| Jan 15, 2026↗ | Kordasiewicz Holly B. | EVP, Chief Development Officer | Sell | 4,141 | $75.66 | $313.3K | 0 |
| Jan 15, 2026↗ | Monia Brett P | Chief Executive Officer | Sell | 44,034 | $74.82 | $3.29M | 0 |
| Jan 15, 2026↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 9,191 | $75.84 | $697.0K | 0 |
| Jan 15, 2026↗ | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | 9,302 | $75.59 | $703.1K | 0 |
| Jan 15, 2026↗ | Swayze Eric | EVP Research | Sell | 9,933 | $75.34 | $748.4K | 0 |
| Jan 9, 2026↗ | Devers Shannon L. | officer: EVP, Chief Human Resources Ofc | Sell | 11,365 | $84.76 | $963.3K | 17,494 |
| Jan 7, 2026↗ | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | 44,199 | $85.08 | $3.76M | 0 |
| Jan 6, 2026↗ | Swayze Eric | officer: EVP Research | Sell | 23,463 | $79.12 | $1.86M | 30,453 |
| Jan 2, 2026↗ | Swayze Eric | EVP Research | Sell | 23,463 | $79.12 | $1.86M | 0 |
| Dec 1, 2025↗ | WENDER JOSEPH H | Director | Sell | 28,000 | $80.82 | $2.26M | 0 |
| Nov 25, 2025↗ | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | 16,777 | $80.91 | $1.36M | 0 |
| Nov 25, 2025↗ | KLEIN JOSEPH III | Director | Sell | 12,000 | $80.00 | $960.0K | 0 |
| Nov 19, 2025↗ | HERMAN JOAN E | Director | Sell | 44,000 | $72.13 | $3.17M | 0 |
| Nov 6, 2025↗ | Birchler Brian | EVP, Corp and Development Ops | Sell | 8,000 | $76.17 | $609.4K | 0 |
| Nov 5, 2025↗ | Geary Richard S | EVP, Chief Development Officer | Sell | 34,639 | $75.69 | $2.62M | 0 |
| Oct 31, 2025↗ | Geary Richard S | EVP, Chief Development Officer | Sell | 90,929 | $75.11 | $6.83M | 0 |
| Oct 31, 2025↗ | LOSCALZO JOSEPH | Director | Sell | 16,000 | $75.10 | $1.20M | 0 |
| Oct 30, 2025↗ | WENDER JOSEPH H | Director | Sell | 28,000 | $74.02 | $2.07M | 0 |
| Oct 15, 2025↗ | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | 7,263 | $73.06 | $530.6K | 0 |
| Oct 15, 2025↗ | PARSHALL B LYNNE | Director | Sell | 5,000 | $71.74 | $358.7K | 0 |
| Oct 15, 2025↗ | Swayze Eric | EVP Research | Sell | 53 | $73.62 | $3.9K | 0 |
| Oct 14, 2025↗ | Birchler Brian | EVP, Corp and Development Ops | Sell | 23,900 | $72.13 | $1.72M | 0 |
| Oct 6, 2025↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 1,625 | $69.37 | $112.7K | 0 |
| Oct 6, 2025↗ | Monia Brett P | Chief Executive Officer | Sell | 437 | $69.26 | $30.3K | 0 |
| Oct 6, 2025↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 13,441 | $69.74 | $937.3K | 0 |
| Oct 6, 2025↗ | Swayze Eric | EVP Research | Sell | 6,849 | $69.02 | $472.7K | 0 |
| Oct 2, 2025↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 15,000 | $68.01 | $1.02M | 0 |
| Oct 2, 2025↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 64,664 | $67.69 | $4.38M | 0 |
| Oct 1, 2025↗ | Swayze Eric | EVP Research | Sell | 27,114 | $66.16 | $1.79M | 0 |
| Oct 1, 2025↗ | WENDER JOSEPH H | Director | Sell | 16,800 | $65.50 | $1.10M | 0 |
| Sep 30, 2025↗ | Geary Richard S | EVP, Chief Development Officer | Sell | 57,900 | $65.24 | $3.78M | 0 |
| Sep 30, 2025↗ | HOUGEN ELIZABETH L | EVP, Finance & CFO | Sell | 49,800 | $65.26 | $3.25M | 0 |
| Sep 29, 2025↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 25,300 | $64.62 | $1.63M | 0 |
| Sep 12, 2025↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 1,700 | $64.58 | $109.8K | 0 |
| Sep 9, 2025↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 11,950 | $62.16 | $742.8K | 0 |
| Sep 9, 2025↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 21,000 | $64.56 | $1.36M | 0 |
| Sep 5, 2025↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 250 | $62.00 | $15.5K | 0 |
| Sep 5, 2025↗ | BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 6,000 | $59.60 | $357.6K | 0 |
| Sep 3, 2025↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 32,800 | $59.34 | $1.95M | 0 |
| Sep 3, 2025↗ | Devers Shannon L. | EVP, Chief Human Resources Ofc | Sell | 3,162 | $61.02 | $192.9K | 0 |
| Sep 3, 2025↗ | KLEIN JOSEPH III | Director | Sell | 56,000 | $60.00 | $3.36M | 0 |
| Sep 3, 2025↗ | LOSCALZO JOSEPH | Director | Sell | 16,000 | $60.15 | $962.4K | 0 |
| Sep 3, 2025↗ | Monia Brett P | Chief Executive Officer | Sell | 203,814 | $60.32 | $12.29M | 0 |
| Sep 3, 2025↗ | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | 19,658 | $60.81 | $1.20M | 0 |
| Sep 2, 2025↗ | BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 38,909 | $59.14 | $2.30M | 0 |
| Sep 2, 2025↗ | Geary Richard S | EVP, Chief Development Officer | Sell | 10,000 | $50.37 | $503.7K | 0 |
| Sep 2, 2025↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 89,900 | $60.03 | $5.40M | 0 |
| Sep 2, 2025↗ | PARSHALL B LYNNE | Director | Sell | 20,000 | $50.92 | $1.02M | 0 |
| Sep 2, 2025↗ | Swayze Eric | EVP Research | Sell | 11,130 | $49.67 | $552.9K | 0 |
| Sep 2, 2025↗ | WENDER JOSEPH H | Director | Sell | 56,000 | $57.58 | $3.22M | 0 |
| Aug 22, 2025↗ | Diaz Allene M. | Director | Sell | 1,427 | $42.53 | $60.7K | 0 |
| Aug 18, 2025↗ | BENNETT C FRANK | EVP, Chief Scientific Officer | Sell | 10,000 | $43.98 | $439.8K | 0 |
| Aug 6, 2025↗ | PARSHALL B LYNNE | Director | Sell | 5,000 | $41.93 | $209.6K | 0 |
| Aug 5, 2025↗ | Geary Richard S | EVP, Chief Development Officer | Sell | 10,000 | $42.86 | $428.6K | 0 |
| Aug 4, 2025↗ | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | Sell | 9,549 | $42.80 | $408.7K | 0 |
| Jul 30, 2025↗ | Monia Brett P | Chief Executive Officer | Sell | 2,432 | $45.00 | $109.4K | 0 |
| Jul 11, 2025↗ | Monia Brett P | Chief Executive Officer | Sell | 1,160 | $41.74 | $48.4K | 0 |
| Apr 15, 2025↗ | Baroldi Joseph | EVP, Chief Business Officer | Sell | 3,928 | $28.40 | $111.6K | 0 |
| Apr 15, 2025↗ | Birchler Brian | EVP, Corp and Development Ops | Sell | 680 | $28.37 | $19.3K | 0 |
| Apr 15, 2025↗ | Jenne Kyle | EVP, Chf GL Pdt Str Ofcr | Sell | 3,016 | $28.36 | $85.5K | 0 |
| Mar 11, 2025↗ | Monia Brett P | Chief Executive Officer | Sell | 140 | $32.32 | $4.5K | 0 |
| Feb 20, 2025↗ | O'NEIL PATRICK R. | EVP CLO & General Counsel | Sell | 1,207 | $32.35 | $39.0K | 0 |
IONS Insiders
Similar Stocks to IONS
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B